5395242026-05-235395242026-05-23Disclosure15395242026-05-23Disclosure25395242026-05-23Disclosure35395242026-05-23Disclosure45395242026-05-23Disclosure55395242026-05-23Disclosure65395242026-05-23Disclosure75395242026-05-23Disclosure8iso4217:INRxbrli:purexbrli:shares539524LALPATHLABNOTLISTEDDR. LAL PATHLABS LIMITEDVINAY GUJRALCompany Secretary and Compliance OfficerGURUGRAM2026-05-23INE600L01024Regulation 7 (2)falseEquityOtherDr. Lal PathLabs Employee Welfare Trust6491460.003920002282400Sell6471460.00392026-05-222026-05-22ESOP2026-05-22NAIt may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of INR 1141.20/- per share under Company’s ESOP plan.EquityDesignated PersonAditya Dhankhar3000275435200Sell2502026-05-062026-05-08Market Sale2026-05-22NSEEquityDesignated PersonAditya Dhankhar250300326241Buy32502026-05-192026-05-19ESOP2026-05-22NAIt may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 1,087.47/- per share under Company’s ESOP Plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. EquityDesignated PersonAditya Dhankhar3250250422092Sell7502026-05-202026-05-21Market Sale2026-05-22NSEEquityDesignated PersonAbhishek Aggarwal130008001340636Sell50002026-05-192026-05-21Market Sale2026-05-22NSEEquityDesignated PersonAbhishek Aggarwal500010001141200Buy150002026-05-222026-05-22ESOP2026-05-22NAIt may be kindly noted that shares were acquired at Effective Exercise price (Post Bonus Issue- 2025) of INR 1141.20/- per share under Company’s ESOP plan.EquityDesignated PersonSanjay Kulshreshtha41280500836250Sell362802026-05-112026-05-11Market Sale2026-05-23NSEEquityDesignated PersonSanjay Kulshreshtha3628010001141200Buy462802026-05-222026-05-22ESOP2026-05-23NAIt may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 1,141.20/- per share under Company’s ESOP Plan.